Aerpio Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 03/11/21
Quantum Leap Healthcare Collaborative Discontinues Testing of Aerpio Pharmaceutical's Razuprotafib in I-SPY COVID TrialGlobeNewsWire • 03/05/21
Aerpio Pharmaceuticals (ARPO) Sees Hammer Chart Pattern: Time to Buy?Zacks Investment Research • 01/06/21
Aerpio Announces Strategic Review after Topline Results from Razuprotafib Glaucoma Phase 2 TrialGlobeNewsWire • 01/05/21
What Makes Aerpio Pharmaceuticals, Inc. (ARPO) a Strong Momentum Stock: Buy Now?Zacks Investment Research • 12/14/20
Aerpio Announces Statistically Significant Topline Results from Razuprotafib Glaucoma Phase 2 TrialGlobeNewsWire • 12/11/20
Aerpio Pharmaceuticals, Inc. (ARPO) Management on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/10/20
Aerpio Reports Third Quarter 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 11/10/20
Aerpio Pharmaceuticals to Report Third Quarter 2020 Financial Results on November 10GlobeNewsWire • 11/05/20
Aerpio Hosting Key Opinion Leader Call on New Therapeutic Agents for COVID-19GlobeNewsWire • 11/05/20
Aerpio Announces First Patient Dosed with Razuprotafib in the Phase 2 Trial for the Prevention and Treatment of ARDS in Patients with Moderate-to-Severe COVID-19GlobeNewsWire • 10/26/20
Aerpio Announces Enrollment Completed in the 28-Day Phase 2 Razuprotafib Glaucoma TrialGlobeNewsWire • 09/15/20
Aerpio and Quantum Leap Announce First Patients Dosed with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-ill COVID-19 PatientsGlobeNewsWire • 09/01/20
Aerpio Pharmaceuticals' (ARPO) Management on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/12/20
Aerpio Reports Second Quarter 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 08/12/20
Aerpio Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 12GlobeNewsWire • 08/10/20
Aerpio Pharmaceuticals, Inc. Announces a Second Clinical Trial with Funding from MTEC to Evaluate Razuprotafib for the Prevention and Treatment of ARDS in Patients with Moderate to Severe COVID-19GlobeNewsWire • 08/04/20
Aerpio Pharmaceuticals, Inc. (ARPO) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research • 06/29/20
Is Aerpio Pharmaceuticals (ARPO) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 06/29/20